$CVSI
CV Sciences, Inc.

2021 Q4 Form 10-Q Financial Statement

#000151096421000076 Filed on November 15, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2020 Q4
Revenue $4.969M $5.107M $5.199M
YoY Change -4.42% -8.21% -44.26%
Cost Of Revenue $3.359M $2.749M $2.978M
YoY Change 12.79% -11.49% -42.49%
Gross Profit $1.610M $2.358M $2.221M
YoY Change -27.51% -4.07% -46.48%
Gross Profit Margin 32.4% 46.17% 42.72%
Selling, General & Admin $10.09M $4.928M $11.41M
YoY Change -11.57% -5.18% 11.96%
% of Gross Profit 626.65% 208.99% 513.69%
Research & Development $364.0K $410.0K
YoY Change -0.49%
% of Gross Profit 22.61% 17.39%
Depreciation & Amortization $407.0K $344.0K $243.0K
YoY Change 67.49% 43.33% 32.79%
% of Gross Profit 25.28% 14.59% 10.94%
Operating Expenses $10.45M $5.338M $11.69M
YoY Change -10.54% -4.83% 1.67%
Operating Profit -$8.843M -$2.980M -$9.464M
YoY Change -6.56% -5.43% 28.88%
Interest Expense -$112.0K -$5.000K -$9.000K
YoY Change 1144.44% -16.67% -169.23%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$8.955M -$40.00K -$9.473M
YoY Change -5.47% -98.73% 29.24%
Income Tax -$98.00K $0.00 -$179.0K
% Of Pretax Income
Net Earnings -$8.857M -$40.00K -$9.294M
YoY Change -4.7% -98.73% 39.01%
Net Earnings / Revenue -178.25% -0.78% -178.77%
Basic Earnings Per Share $0.00
Diluted Earnings Per Share -$80.54K $0.00 -$92.79K
COMMON SHARES
Basic Shares Outstanding 110.7M shares 109.1M shares 100.0M shares
Diluted Shares Outstanding 109.1M shares

Balance Sheet

Concept 2021 Q4 2021 Q3 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.375M $1.660M $4.024M
YoY Change -65.83% -70.16% -55.81%
Cash & Equivalents $1.375M $1.660M $4.024M
Short-Term Investments
Other Short-Term Assets $2.146M $1.919M $2.873M
YoY Change -25.3% -77.79% -74.15%
Inventory $8.624M $8.876M $8.840M
Prepaid Expenses $2.146M $2.372M
Receivables $2.041M $1.759M $1.126M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $14.19M $14.21M $16.86M
YoY Change -15.87% -41.28% -47.9%
LONG-TERM ASSETS
Property, Plant & Equipment $1.717M $2.148M $2.877M
YoY Change -40.32% -30.62% -20.41%
Goodwill $0.00 $2.788M $2.788M
YoY Change -100.0% 0.0% 0.0%
Intangibles $1.485M $3.730M $3.730M
YoY Change -60.19%
Long-Term Investments
YoY Change
Other Assets $678.0K $730.0K $1.310M
YoY Change -48.24% -47.02% -9.15%
Total Long-Term Assets $3.880M $9.396M $13.76M
YoY Change -71.81% -33.83% -32.27%
TOTAL ASSETS
Total Short-Term Assets $14.19M $14.21M $16.86M
Total Long-Term Assets $3.880M $9.396M $13.76M
Total Assets $18.07M $23.61M $30.63M
YoY Change -41.01% -38.52% -41.87%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.624M $1.509M $1.677M
YoY Change 56.47% -8.38% 3.71%
Accrued Expenses $10.92M $10.80M $9.805M
YoY Change 11.32% 10.03% -9.68%
Deferred Revenue
YoY Change
Short-Term Debt $612.0K $0.00 $0.00
YoY Change
Long-Term Debt Due $310.0K $0.00 $2.174M
YoY Change -85.74% -100.0%
Total Short-Term Liabilities $14.46M $12.31M $14.34M
YoY Change 0.87% -1.63% 8.64%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $1.453M
YoY Change -100.0% -100.0%
Other Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change -100.0%
Total Long-Term Liabilities $0.00 $0.00 $1.453M
YoY Change -100.0% 257.88%
TOTAL LIABILITIES
Total Short-Term Liabilities $14.46M $12.31M $14.34M
Total Long-Term Liabilities $0.00 $0.00 $1.453M
Total Liabilities $14.52M $12.47M $19.41M
YoY Change -25.19% -34.23% -17.53%
SHAREHOLDERS EQUITY
Retained Earnings -$79.48M -$70.62M -$63.92M
YoY Change 24.33% 29.27% 53.52%
Common Stock $11.00K $11.00K $10.00K
YoY Change 10.0% 10.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.543M $11.14M $11.21M
YoY Change
Total Liabilities & Shareholders Equity $18.07M $23.61M $30.63M
YoY Change -41.01% -38.52% -41.87%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2020 Q4
OPERATING ACTIVITIES
Net Income -$8.857M -$40.00K -$9.294M
YoY Change -4.7% -98.73% 39.01%
Depreciation, Depletion And Amortization $407.0K $344.0K $243.0K
YoY Change 67.49% 43.33% 32.79%
Cash From Operating Activities -$1.164M -$1.568M -$1.468M
YoY Change -20.71% -9.26% -68.27%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 -$263.0K
YoY Change -100.0% -100.0% 6.91%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 $0.00 -$263.0K
YoY Change -100.0% -100.0% 6.91%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 879.0K 267.0K 192.0K
YoY Change 357.81% 8800.0% -20.66%
NET CHANGE
Cash From Operating Activities -1.164M -1.568M -1.468M
Cash From Investing Activities 0.000 0.000 -263.0K
Cash From Financing Activities 879.0K 267.0K 192.0K
Net Change In Cash -285.0K -1.301M -1.539M
YoY Change -81.48% -35.37% -66.76%
FREE CASH FLOW
Cash From Operating Activities -$1.164M -$1.568M -$1.468M
Capital Expenditures $0.00 $0.00 -$263.0K
Free Cash Flow -$1.164M -$1.568M -$1.205M
YoY Change -3.4% 8.89% -72.49%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001510964
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
http://fasb.org/us-gaap/2021-01-31#ProductMember
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-54677
dei Entity Registrant Name
EntityRegistrantName
CV Sciences, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
80-0944970
dei Entity Address Address Line1
EntityAddressAddressLine1
10070 Barnes Canyon Road
dei Entity Address City Or Town
EntityAddressCityOrTown
San Diego
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92121
dei City Area Code
CityAreaCode
866
dei Local Phone Number
LocalPhoneNumber
290-2157
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
110687784 shares
CY2021Q3 us-gaap Cash
Cash
1660000 USD
CY2020Q4 us-gaap Cash
Cash
4024000 USD
CY2021Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
0 USD
CY2020Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
501000 USD
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1759000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1126000 USD
CY2021Q3 us-gaap Inventory Net
InventoryNet
8876000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
8840000 USD
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1919000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2372000 USD
CY2021Q3 us-gaap Assets Current
AssetsCurrent
14214000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
16863000 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2148000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2877000 USD
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
0 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3057000 USD
CY2021Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3730000 USD
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3730000 USD
CY2021Q3 us-gaap Goodwill
Goodwill
2788000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
2788000 USD
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
730000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1310000 USD
CY2021Q3 us-gaap Assets
Assets
23610000 USD
CY2020Q4 us-gaap Assets
Assets
30625000 USD
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1509000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1677000 USD
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
10802000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9805000 USD
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
0 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
680000 USD
CY2021Q3 us-gaap Notes Payable Current
NotesPayableCurrent
0 USD
CY2020Q4 us-gaap Notes Payable Current
NotesPayableCurrent
2174000 USD
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
12311000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
14336000 USD
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3467000 USD
CY2021Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
0 USD
CY2020Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
1453000 USD
CY2021Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
157000 USD
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
157000 USD
CY2021Q3 us-gaap Liabilities
Liabilities
12468000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
19413000 USD
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
190000000 shares
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
190000000 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
109946000 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
109946000 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
100664000 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
100664000 shares
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
11000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
10000 USD
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
81749000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
75123000 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-70618000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-63921000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
11142000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
11212000 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
23610000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
30625000 USD
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5107000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5564000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15079000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
19230000 USD
CY2021Q3 us-gaap Cost Of Revenue
CostOfRevenue
2749000 USD
CY2020Q3 us-gaap Cost Of Revenue
CostOfRevenue
3106000 USD
us-gaap Cost Of Revenue
CostOfRevenue
8073000 USD
us-gaap Cost Of Revenue
CostOfRevenue
10442000 USD
CY2021Q3 us-gaap Gross Profit
GrossProfit
2358000 USD
CY2020Q3 us-gaap Gross Profit
GrossProfit
2458000 USD
us-gaap Gross Profit
GrossProfit
7006000 USD
us-gaap Gross Profit
GrossProfit
8788000 USD
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
410000 USD
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
412000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
821000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2667000 USD
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4928000 USD
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5197000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
15788000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
19249000 USD
CY2021Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
5338000 USD
CY2020Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
5609000 USD
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
16609000 USD
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
21916000 USD
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2980000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3151000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-9603000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-13128000 USD
CY2021Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
2945000 USD
CY2020Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
2945000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2021Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-5000 USD
CY2020Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-6000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-28000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
0 USD
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-40000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3157000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6686000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-13128000 USD
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-138000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-40000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-3157000 USD
us-gaap Net Income Loss
NetIncomeLoss
-6697000 USD
us-gaap Net Income Loss
NetIncomeLoss
-12990000 USD
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
109115000 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
109115000 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
99950000 shares
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
99950000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
107099000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
107099000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
99831000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
99831000 shares
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
0 USD
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
11212000 USD
CY2021Q1 cvsi Stock Issued During Period Value Equity Commitment
StockIssuedDuringPeriodValueEquityCommitment
3222000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
657000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-3127000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
11964000 USD
CY2021Q2 cvsi Stock Issued During Period Value Equity Commitment
StockIssuedDuringPeriodValueEquityCommitment
631000 USD
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
912000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-3530000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
9977000 USD
CY2021Q3 cvsi Stock Issued During Period Value Equity Commitment
StockIssuedDuringPeriodValueEquityCommitment
399000 USD
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
806000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-40000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
11142000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
29147000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
161000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1258000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-5152000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
25414000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
12000 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1243000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-4681000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
21988000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3000 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
615000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-3157000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
19449000 USD
us-gaap Net Income Loss
NetIncomeLoss
-6697000 USD
us-gaap Net Income Loss
NetIncomeLoss
-12990000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
746000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
629000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
2375000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
3116000 USD
cvsi Noncash Lease Expense
NoncashLeaseExpense
284000 USD
cvsi Noncash Lease Expense
NoncashLeaseExpense
455000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
2945000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
906000 USD
us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
352000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
0 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-176000 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
220000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
158000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
240000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
695000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-717000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
36000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1858000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-916000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2640000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
417000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2163000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6321000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5832000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
35000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
794000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-35000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-794000 USD
us-gaap Proceeds From Unsecured Notes Payable
ProceedsFromUnsecuredNotesPayable
0 USD
us-gaap Proceeds From Unsecured Notes Payable
ProceedsFromUnsecuredNotesPayable
2906000 USD
us-gaap Repayments Of Unsecured Debt
RepaymentsOfUnsecuredDebt
721000 USD
us-gaap Repayments Of Unsecured Debt
RepaymentsOfUnsecuredDebt
0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4212000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
176000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3491000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3082000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2865000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3544000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4525000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9608000 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1660000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6064000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
18000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
0 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
239000 USD
cvsi Sale Of Property And Equipment In Exchange For Prepaid Expenses And Other And Inventory
SaleOfPropertyAndEquipmentInExchangeForPrepaidExpensesAndOtherAndInventory
0 USD
cvsi Sale Of Property And Equipment In Exchange For Prepaid Expenses And Other And Inventory
SaleOfPropertyAndEquipmentInExchangeForPrepaidExpensesAndOtherAndInventory
675000 USD
cvsi Right Of Use Asset Foregone In Exchange For Reduction In Operating Lease Liability
RightOfUseAssetForegoneInExchangeForReductionInOperatingLeaseLiability
-2773000 USD
cvsi Right Of Use Asset Foregone In Exchange For Reduction In Operating Lease Liability
RightOfUseAssetForegoneInExchangeForReductionInOperatingLeaseLiability
-4704000 USD
us-gaap Line Of Credit Facility Decrease Forgiveness1
LineOfCreditFacilityDecreaseForgiveness1
2945000 USD
us-gaap Line Of Credit Facility Decrease Forgiveness1
LineOfCreditFacilityDecreaseForgiveness1
0 USD
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segment
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The preparation of the condensed financial statements in conformity with U.S. GAAP requires management to make judgments, estimates and assumptions that affect the reported amounts in the condensed financial statements and accompanying notes. Actual results may differ from these estimates. Significant estimates include the valuation of intangible assets, inputs for valuing equity awards, valuation of inventory and assumptions related to revenue recognition.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior year amounts related to the gain on lease termination of $0.4 million have been reclassified from changes in operating assets and liabilities to a separate line item in the condensed statements of cash flows for consistency with the current year presentation. These reclassifications had no impact on the Company's net cash used in operating activities or total cash flows.</span></div>
CY2020 us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
400000 USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1660000 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5563000 USD
CY2021Q3 us-gaap Restricted Cash
RestrictedCash
0 USD
CY2020Q3 us-gaap Restricted Cash
RestrictedCash
501000 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1660000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6064000 USD
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5107000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5564000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15079000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
19230000 USD
CY2021Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
4640000 USD
CY2020Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
4923000 USD
CY2021Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
1522000 USD
CY2020Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
785000 USD
CY2021Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2714000 USD
CY2020Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
3132000 USD
CY2021Q3 us-gaap Inventory Gross
InventoryGross
8876000 USD
CY2020Q4 us-gaap Inventory Gross
InventoryGross
8840000 USD
CY2021Q3 us-gaap Inventory Write Down
InventoryWriteDown
100000 USD
us-gaap Inventory Write Down
InventoryWriteDown
200000 USD
CY2020Q3 us-gaap Inventory Write Down
InventoryWriteDown
100000 USD
us-gaap Inventory Write Down
InventoryWriteDown
400000 USD
CY2021Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
8616000 USD
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
8324000 USD
CY2021Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2186000 USD
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1481000 USD
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
10802000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9805000 USD
CY2020Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
3627000 USD
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
2174000 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1453000 USD
CY2021Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
0 USD
CY2021Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
3000000.0 USD
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y1M24D
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.329
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.337
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.329
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.004
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.009
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.005
CY2020Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y10M6D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y7M9D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y3M25D
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.47
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.49
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.36
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
31141000 shares
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
26155000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
31141000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
26155000 shares
CY2021Q2 cvsi Number Of Shareholder Derivative Suits
NumberOfShareholderDerivativeSuits
5 lawsuit
cvsi Number Of Shareholder Derivative Suits Stayed
NumberOfShareholderDerivativeSuitsStayed
4 lawsuit
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segment
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5107000 USD
CY2021Q3 us-gaap Gross Profit
GrossProfit
2358000 USD
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
410000 USD
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4928000 USD
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2980000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5564000 USD
CY2020Q3 us-gaap Gross Profit
GrossProfit
2458000 USD
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
412000 USD
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5197000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3151000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15079000 USD
us-gaap Gross Profit
GrossProfit
7006000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
821000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
15788000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-9603000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
19230000 USD
us-gaap Gross Profit
GrossProfit
8788000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2667000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
19249000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-13128000 USD
cvsi Net Operating Loss Tax Benefit Recognized
NetOperatingLossTaxBenefitRecognized
0 USD
cvsi Net Operating Loss Tax Benefit Recognized
NetOperatingLossTaxBenefitRecognized
0 USD
CY2020Q4 cvsi Employee Portion Of Payroll Taxes Paid
EmployeePortionOfPayrollTaxesPaid
200000 USD

Files In Submission

Name View Source Status
0001510964-21-000076-index-headers.html Edgar Link pending
0001510964-21-000076-index.html Edgar Link pending
0001510964-21-000076.txt Edgar Link pending
0001510964-21-000076-xbrl.zip Edgar Link pending
cvsi-20210930.htm Edgar Link pending
cvsi-20210930.xsd Edgar Link pending
cvsi-20210930xex311.htm Edgar Link pending
cvsi-20210930xex312.htm Edgar Link pending
cvsi-20210930xex321.htm Edgar Link pending
cvsi-20210930xex322.htm Edgar Link pending
cvsi-20210930_cal.xml Edgar Link unprocessable
cvsi-20210930_def.xml Edgar Link unprocessable
cvsi-20210930_htm.xml Edgar Link completed
cvsi-20210930_lab.xml Edgar Link unprocessable
cvsi-20210930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending